Dr Reddys Laboratories Ltd RDY Income Statements

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NYSE
Dr Reddys Laboratories Ltd (RDY)
Dr Reddys Laboratories Ltd (RDY) Financials

Dr Reddys Laboratories Ltd (RDY)

15.37

0.25

(1.65%)

Closed December 20 3:00PM

Delayed by 15 minutes

15.40

0.03

( 0.20% )

Pre Market: 4:11AM

Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Annual Quarterly

Quarter End	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	INR (₨)	INR (₨)	INR (₨)	INR (₨)	INR (₨)	INR (₨)	INR (₨)	INR (₨)
Total Revenue	67.7B	62.97B	67.38B	68.8B	72.15B	70.83B	76.73B	80.16B
Operating Income	16.62B	-33.94B	17.69B	17.52B	17.4B	14.83B	17.99B	18.09B
Pre Tax Income	16.35B	13.26B	18.46B	19.13B	18.26B	16.02B	18.82B	19.17B
Net Income	12.47B	9.59B	14.03B	14.8B	13.79B	13.07B	13.92B	12.55B
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	0	0	0	0	0	0	0	0
EBIT	16.62B	-33.94B	17.69B	17.96B	17.4B	14.82B	17.99B	18.54B
EBITDA	16.62B	-43.38B	17.69B	24.88B	17.4B	18.55B	17.99B	25.87B

Year End March 30 2024	2017	2018	2019	2020	2021	2022	2023	2024
	INR (₨)	INR (₨)	INR (₨)	INR (₨)	INR (₨)	INR (₨)	INR (₨)	INR (₨)
Total Revenue	141.76B	142.89B	154.42B	178.76B	190.62B	216.11B	252.99B	282.45B
Operating Income	14.49B	12.82B	20.79B	34.25B	34.08B	36.76B	59.76B	67.4B
Pre Tax Income	15.54B	13.5B	22.92B	18.86B	28.84B	30.61B	60.49B	72.01B
Net Income	12.92B	9.47B	19.5B	20.26B	19.52B	21.83B	45.07B	55.78B
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	77.959	57.067	117.423	121.901	117.353	131.139	270.663	334.37
EBIT	14.49B	12.82B	20.37B	34.06B	34.08B	36.76B	59.76B	67.4B
EBITDA	24.76B	23.6B	32.14B	45.88B	46.37B	48.41B	72.26B	82.14B

Dr Reddys Laboratories

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions